https://orcid.org/0000-0003-4370-6313
References
- Pérez-Gracia MT, Fernandez C, Cebriab BM. Chronic Hyperplastic Candidiasis of the oral mucosa: case report. HSOA J Clin Stud Med Case Rep. 2014;1(1):1–3. doi:10.24966/CSMC-8801/100001
- Shetti A, Gupta I, Charantimath SM. Oral candidiasis: aiding in the diagnosis of HIV—a case report. Hindawi Publishing Corporation Case Reports in Dentistry. 2011;2011:1–4. doi:10.1155/2011/929616
- Keser G, Öztürk M, Namdar Pekiner F. Assessment of Awareness and Knowlwdge of Oral Cancer Among Tobacco Using Dental Patients. Clin Exp Health Sci. 2021;11:279–284. doi:10.33808/clinexphealthsci.862928
- Danwang C, Noubiap JJ, Robert A, Yombi JC. Outcomes of patients with HIV and COVID-19 co-infection: a systematic review and meta-analysis. AIDS Res Ther. 2022;19(1):1–12. doi:10.1186/s12981-021-00427-y
- Shah N, Ray JG, Kundu S, Sardana D. Surgical management of chronic hyperplastic candidiasis refractory to systemic antifungal treatment. J Lab Physicians. 2017;9(02):136–139. doi:10.4103/0974-2727.199622
- Nathania E, Widjaja JT. Candidiasis as secondary infection in post COVID-19: a new problem? J Respirasi. 2021;7(3):127. doi:10.20473/jr.v7-I.3.2021.127-133
- Nanteza M, Tusiime JB, Kalyango J, Kasangaki A. Association between oral candidiasis and low CD4+ count among HIV positive patients in Hoima regional referral hospital. BMC Oral Health. 2014;14(143):1–6. doi:10.1186/1472-6831-14-143
- Wu YC, Chen CS, Chan YJ. The outbreak of COVID-19: an overview. J Chin Med Assoc. 2020 doi:;83:217–220. doi:10.1097/JCMA.0000000000000270
- Peng X, Ouyang J, Isnard S, et al. Sharing CD4+ T cell loss: when COVID-19 and HIV collide on immune system. Front Immunol. 2020;11(December):1–11. doi:10.3389/fimmu.2020.596631
- Gatechompol S, Avihingsanon A, Putcharoen O, Ruxrungtham K, Kuritzkes DR. COVID-19 and HIV infection co-pandemics and their impact: a review of the literature. AIDS Res Ther. 2021;18(1):1–9. doi:10.1186/s12981-021-00335-1
- Putranti A, Asmarawati TP, Rachman BE, Nasronudin HU. Oral candidiasis as clinical manifestation of HIV/AIDS infection in Airlangga University hospital patients. IOP Conf Ser Earth Environ Sci. 2018;125(1):012063. doi:10.1088/1755-1315/125/1/012063
- Suryana K, Suharsono H, Antara IGPJ. Factors associated with oral candidiasis in people living with HIV/AIDS: a case control study. HIV/AIDS Res Palliat Care. 2020;12:33–39. doi:10.2147/HIV.S236304
- Riou C, du Bruyn E, Stek C, et al. Relationship of SARS-CoV-2–specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection. J Clin Invest. 2021;131(12):1–15. doi:10.1172/JCI149125
- Yang Y, Iwasaki A. Impact of Chronic HIV Infection on SARS-Cov-2 Infection, COVID-19 Disease and Vaccines [Internet]. The Global Epidemic; 2021:5–16. doi:10.1007/s11904-021-00590-x
- Piliang A, Zakiawati D, Nur’aeny N. Xerostomia as a potential condition in patients COVID-19 with tetanus: a case report. Makassar Dent J. 2022;11(1):21–24. doi:10.35856/mdj.v11i1.501
- Lyu X, Zhao C, Yan ZM, Hua H. Efficacy of nystatin for the treatment of oral candidiasis: a systematic review and meta-analysis. Drug Des Devel Ther. 2016;16(10):1161–1171. doi:10.2147/DDDT.S100795
- Brookes ZLS, Bescos R, Belfield LA, Ali K, Roberts A. Current uses of chlorhexidine for management of oral disease: a narrative review. J Dent. 2020;103:103497. doi:10.1016/j.jdent.2020.103497
- Garcia-Cuesta C, Sarrion-Pérez MG, Bagán JV. Current treatment of oral candidiasis: a literature review. J Clin Exp Dent. 2014;6(5):e576–e582. doi:10.4317/jced.51798